Ophthalmology
Review: Virtual consultation for red eye.
30 Jun, 2021 | 10:04h | UTCVirtual consultation for red eye – The BMJ
Commentary on Twitter
Red eye is a common ophthalmic presentation in primary care, accounting for 2 to 3% of the consultations.
How can you safely diagnose and manage patients with acute red eye(s) in a virtual consultation?https://t.co/cn12VYpyuW
— The BMJ (@bmj_latest) June 29, 2021
Pragmatic RCT: Among patients with advanced glaucoma, primary trabeculectomy resulted in similar quality of life and safety outcomes and achieved a lower intraocular pressure compared with primary medication.
17 May, 2021 | 08:06h | UTC
Update on Corneal Transplant in 2021
20 Apr, 2021 | 05:33h | UTCUpdate on Corneal Transplant in 2021 – JAMA (free for a limited period)
Study: Teprotumumab for patients with active thyroid eye disease
20 Apr, 2021 | 05:25h | UTCTeprotumumab for patients with active thyroid eye disease: a pooled data analysis, subgroup analyses, and off-treatment follow-up results from two randomised, double-masked, placebo-controlled, multicentre trials – The Lancet Diabetes & Endocrinology (link to abstract – $ for full-text)
Study suggests treatment not always needed to prevent vision loss in patients with elevated eye pressure
18 Apr, 2021 | 21:01h | UTCOriginal study: Assessment of Cumulative Incidence and Severity of Primary Open-Angle Glaucoma Among Participants in the Ocular Hypertension Treatment Study After 20 Years of Follow-up – JAMA Ophthalmology (free for a limited period)
Commentary on Twitter
Only 25% of the OHTS participants developed visual field loss over 20 years of follow-up https://t.co/2DV1gr0cbM
— JAMA Ophthalmology (@JAMAOphth) April 15, 2021
AHA Scientific Statement: Management of Central Retinal Artery Occlusion
13 Apr, 2021 | 05:10h | UTCCommentaries: Stroke affecting the eye requires immediate treatment, can signal future vascular events – American Heart Association AND AHA Issues Statement on Central Retinal Artery Occlusion – HealthDay
RCT: Effect of intravitreous anti–vascular endothelial growth factor vs. sham treatment for prevention of vision-threatening complications of diabetic retinopathy
6 Apr, 2021 | 01:02h | UTCCommentaries: Preventive treatment reduces diabetic retinopathy complications – NIH News Releases AND Prevention of Severe Nonproliferative Diabetic Retinopathy Progression With More at Stake Than Visual Acuity – JAMA Ophthalmology AND Practicality of Prophylactic Aflibercept to Reduce Diabetic Retinopathy Progression – JAMA Ophthalmology
Author interview: Randomized Trial of Anti-VEGF to Prevent Proliferative Diabetic Retinopathy (PDR) and Diabetic Macular Edema (DME) – JAMA
Commentary on Twitter
In this study, aflibercept injections reduced the development of vision-threating complications; however, through 2 years, preventive treatment did not confer visual acuity benefit compared with observation plus aflibercept if complications developed https://t.co/q4ABSKOMVj
— JAMA Ophthalmology (@JAMAOphth) March 30, 2021
RCT: Efficacy and safety of a dexamethasone intracanalicular insert in patients with allergic conjunctivitis
5 Apr, 2021 | 00:54h | UTCPhase 3 Randomized Study of Efficacy and Safety of a Dexamethasone Intracanalicular Insert in Patients With Allergic Conjunctivitis – American Journal of Ophthalmology (link to abstract – $ for full-text)
Systematic review: Lens extraction for chronic angle-closure glaucoma
2 Apr, 2021 | 09:01h | UTCLens extraction for chronic angle-closure glaucoma – Cochrane Library
Systematic review: Laser peripheral iridoplasty for chronic angle closure
2 Apr, 2021 | 09:02h | UTCLaser peripheral iridoplasty for chronic angle closure – Cochrane Library
Systematic review: Lens extraction for chronic angle‐closure glaucoma
26 Mar, 2021 | 08:22h | UTCLens extraction for chronic angle‐closure glaucoma – Cochrane Library
Joint Statement: Hydroxychloroquine use with respect to retinal toxicity
28 Feb, 2021 | 20:41h | UTCCommentary: Societies Agree on Eye Safety for HCQ – MedPage Today (free registration required) AND ACR, medical societies reach consensus on hydroxychloroquine retinopathy – Healio (free registration required)
Commentary on Twitter
🆕 Joint statement on #Hydroxychloroquine use with respect to retinal toxicity 👀 by several #rheumatology and #opthtalmology societies. #ocular #toxicity relates to #HCQ dosage and duration of use and is seen in 4.3% to 13.8% of patients 🔎#Lupus #SLEhttps://t.co/ocFSCmgVsN
— Laurent ARNAUD (@Lupusreference) February 18, 2021
Experts worry screen time during Covid-19 could increase vision problems in kids
23 Feb, 2021 | 01:48h | UTCRelated: Progression of myopia in school-aged children after COVID-19 home confinement – JAMA Ophthalmology
The Lancet Commission on Global Eye Health: Vision Beyond 2020
19 Feb, 2021 | 02:38h | UTCGlobal Eye Health: vision beyond 2020 – The Lancet Global Health
Commentary on Twitter
NEW—Eliminating preventable sight loss could bring economic benefits of US$411 billion a year, unlock human potential & accelerate global development. @LancetGH #GlobalEyeHealth Commission reports on action needed now to deliver key 👁️ health services. https://t.co/aLNmwKVENB pic.twitter.com/u69JFGL2BY
— The Lancet (@TheLancet) February 17, 2021
Ocular MRI findings in patients with severe COVID-19
17 Feb, 2021 | 01:42h | UTCCommentaries: New COVID-19 side effect: MRI links severe infection to dangerous eye problems – Health Imaging AND MRI illuminates COVID-19’s negative impact on the eyes – AuntMinnie AND Windows of Infection: MRI Reveals COVID-19-Linked Eye Abnormalities – Diagnostic Imaging
Pediatric eye injuries by hydroalcoholic gel in the context of the Covid-19 Pandemic
12 Feb, 2021 | 02:12h | UTCCase series: Hand Sanitizer–Induced Ocular Injury: A COVID-19 Hazard in Children – JAMA Ophthalmology
Invited commentary: Unintended Consequences of Hand Sanitizer Use in the Coronavirus Disease 2019 Pandemic – JAMA Ophthalmology
State of the Art Review: Uveitis for the non-ophthalmologist
4 Feb, 2021 | 01:22h | UTCUveitis for the non-ophthalmologist – The BMJ (free for a limited period)
Systematic review: Worldwide incidence and prevalence of Neuromyelitis Optica
29 Jan, 2021 | 01:31h | UTCWorldwide Incidence and Prevalence of Neuromyelitis Optica: A Systematic Review – Neurology
Referral for disease-related visual impairment using retinal photograph-based deep learning: a proof-of-concept, model development study
22 Jan, 2021 | 08:16h | UTCInvited commentary: AI-automated referral for patients with visual impairment – The Lancet Digital Health
Commentary on Twitter
NEW Research: ‘Referral for disease-related visual impairment using #retinal photograph-based #DeepLearning: a proof-of-concept, model development study’. @snec_seri @dukenus @Astarhq @NTUsg @CUHKMedicine @SurajEye @UniHeidelberg @WestmeadInst @NUSMedicinehttps://t.co/iwCwYePLeu pic.twitter.com/Qksm3uPPVu
— The Lancet Digital Health (@LancetDigitalH) December 23, 2020
Predicting the risk of developing diabetic retinopathy using deep learning
22 Jan, 2021 | 08:15h | UTC
Commentary on Twitter
NEW Research: 'Predicting the risk of developing diabetic #retinopathy using deep learning'. #diabetes #DeepLearning @GoogleHealth @AdvClinical @RangsitU https://t.co/fstZJAWu4n pic.twitter.com/qC3AC10i7y
— The Lancet Digital Health (@LancetDigitalH) November 27, 2020
Progression of myopia in school-aged children after COVID-19 home confinement
15 Jan, 2021 | 08:55h | UTCProgression of Myopia in School-Aged Children After COVID-19 Home Confinement – JAMA Ophthalmology
Commentaries: 2020 as the Year of Quarantine Myopia – JAMA Ophthalmology AND How Does Home Confinement Impact Children’s Eyesight? – AJMC AND COVID-19: Home Quarantine Linked to Increase in Myopia Among Younger Children – NEJM Journal Watch AND Vision problems arise in young school kids in COVID-19 quarantine – CIDRAP
Interview: 2020 as the Year of Quarantine Myopia
Randomized trial: Surgical and drug treatment options lead to similar outcomes for diabetic eye disease
15 Jan, 2021 | 08:22h | UTCOriginal Study: Effect of Intravitreous Aflibercept vs Vitrectomy With Panretinal Photocoagulation on Visual Acuity in Patients With Vitreous Hemorrhage From Proliferative Diabetic Retinopathy: A Randomized Clinical Trial – JAMA (link to abstract – $ for full-text)
Commentary on Twitter
In this RCT, intravitreous aflibercept vs vitrectomy + panretinal photocoagulation did not improve visual acuity over 24 weeks in patients with vitreous hemorrhage from proliferative diabetic retinopathy; the study may have been underpowered https://t.co/n4px6kFF5Z
— JAMA (@JAMA_current) December 18, 2020
Trends in prevalence of blindness and distance and near vision impairment over 30 years: an analysis for the Global Burden of Disease Study
16 Dec, 2020 | 09:57h | UTCCommentary: Researchers Say We’re Watching The World Go Blind – Michigan Medicine – University of Michigan
Commentaries on Twitter
Two new studies on the causes and trends of blindness and vision impairment show the world is not meeting targets to reduce avoidable sight loss. Both studies are available online in @LancetGH.
Causes: https://t.co/j0y0poscj1
Trends: https://t.co/DPT8jKLyVx pic.twitter.com/aKxlvqvv2B— Institute for Health Metrics and Evaluation (IHME) (@IHME_UW) December 2, 2020
(thread – click for more)
https://twitter.com/DrJSteinmetz/status/1334272298141016069
Randomized trial: Short-term topical tetracaine is highly efficacious for the treatment of pain caused by corneal abrasions
2 Nov, 2020 | 02:17h | UTC
[Abstract Only] Randomized trial: Effect of High add power, medium add power, or single-vision contact lenses on myopia progression in children
2 Sep, 2020 | 09:33h | UTCCommentaries: Multifocal contact lenses slow myopia progression in children – NIH News Releases AND Young nearsighted kids benefit from bifocal contact lenses, study shows – Ohio State University